On March 21, 2022, Aubrey Rankin provided notice of his resignation as a member of the Board of Directors of Revance Therapeutics, Inc. (the Company), effective as of the date of the Company's 2022 Annual Meeting of Stockholders. Mr. Rankin's decision is not a result of any disagreement on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | -1.73% | +4.80% | -67.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.69% | 297M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Revance Therapeutics, Inc. Announce Resignation of Aubrey Rankin as A Member of the Board of Directors